A breakthrough in microbiome research could change how colorectal cancer is detected—no colonoscopy required. Scientists used AI to map gut bacteria at an unprecedented level of detail, revealing ...
Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).
It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...
A second blood test shows promise for the detection of colon cancer, according to a new study. The first, called Shield, was approved by the Food and Drug Administration in July for people 45 and ...
Add Yahoo as a preferred source to see more of our stories on Google. Blood tests are emerging as an innovative tool for colorectal cancer detection because they have the potential to save lives ...
In 2024, the Food and Drug Administration (FDA) approved a blood test that can screen for colorectal cancer in people older than 45 years old at average risk for the disease. Some people may skip ...
The Food and Drug Administration (FDA) has recently approved a blood test that can assist in the primary detection of colorectal cancer. This test could assist with prompt detection and intervention ...
Overall, the incidence of colorectal cancer has decreased over the decades, largely in part due to the use of screening ...
A Miami man credits a routine blood test with saving his life after early-stage colon cancer was found via colonoscopy, ...
Add Yahoo as a preferred source to see more of our stories on Google. KTALnews.com (KTAL/KMSS) – With March being National Colorectal Cancer Awareness Month, there’s never been a better time to screen ...
A gastrointestinal doctor reveals the mistakes you should avoid if you want to lower your risk of colon cancer.
Please provide your email address to receive an email when new articles are posted on . A blood-based test demonstrated high sensitivity for colorectal cancer among individuals with average risk. The ...